Citizens (CIA)
(Delayed Data from NYSE)
$3.16 USD
-0.06 (-1.86%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $3.17 +0.01 (0.32%) 7:58 PM ET
2-Buy of 5 2
A Value F Growth C Momentum C VGM
Income Statements
Fiscal Year end for Citizens, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 241 | 233 | 251 | 239 | 251 |
Cost Of Goods | 180 | 192 | 198 | 189 | 189 |
Gross Profit | 61 | 41 | 53 | 50 | 62 |
Selling & Adminstrative & Depr. & Amort Expenses | 35 | 48 | 59 | 62 | 56 |
Income After Depreciation & Amortization | 26 | -7 | -7 | -12 | 6 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 26 | -7 | -7 | -12 | 6 |
Income Taxes | 2 | 0 | -43 | -1 | 7 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 24 | -7 | 37 | -11 | -1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 24 | -7 | 37 | -11 | -1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 32 | -1 | 14 | -1 | 22 |
Depreciation & Amortization (Cash Flow) | 6 | 6 | 21 | 11 | 16 |
Income After Depreciation & Amortization | 26 | -7 | -7 | -12 | 6 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 50.68 | 50.87 | 50.39 | 49.40 | 45.67 |
Diluted EPS Before Non-Recurring Items | 0.48 | -0.13 | 0.98 | -0.03 | -0.03 |
Diluted Net EPS (GAAP) | 0.48 | -0.13 | 0.73 | -0.22 | -0.03 |
Fiscal Year end for Citizens, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 62.08 | 57.71 | 66.85 | 59.39 | 58.53 |
Cost Of Goods | 48.26 | 45.57 | 50.63 | 45.73 | 42.93 |
Gross Profit | 13.82 | 12.14 | 16.22 | 13.67 | 15.60 |
SG&A, R&D, and Dept/Amort Expenses | 10.52 | 7.22 | 7.44 | 9.02 | 9.55 |
Income After SG&A, R&D, and Dept/Amort Expenses | 3.30 | 4.92 | 8.78 | 4.65 | 6.05 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 3.30 | 4.93 | 8.77 | 4.64 | 6.04 |
Income Taxes | -0.66 | 0.38 | -1.97 | 1.94 | -0.08 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 3.96 | 4.54 | 10.74 | 2.70 | 6.13 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 3.96 | 4.54 | 10.74 | 2.70 | 6.13 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 49.49 | 50.56 | 51.15 | 50.52 | 50.55 |
Diluted EPS Before Non-Recurring Items | 0.08 | 0.09 | 0.21 | 0.05 | 0.12 |
Diluted Net EPS (GAAP) | 0.08 | 0.09 | 0.21 | 0.05 | 0.12 |